Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

Item
http://www.wikidata.org/entity/Q34117145
Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast CancerProgesterone-targeted magnetic resonance imaging probesSynthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancersA steroid-conjugated magnetic resonance probe enhances contrast in progesterone receptor expressing organs and tumors in vivo.Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.Targeting lysyl oxidase for molecular imaging in breast cancer.Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.Molecular imaging probes for diagnosis and therapy evaluation of breast cancerAutomated synthesis and dosimetry of 6-deoxy-6-[(18)F]fluoro-D-fructose (6-[(18)F]FDF): a radiotracer for imaging of GLUT5 in breast cancer.Diagnostic and prognostic application of positron emission tomography in breast imaging: emerging uses and the role of PET in monitoring treatment response.Molecular imaging using PET for breast cancer.Small Molecules for Active Targeting in Cancer.Hydrogen-bond promoted nucleophilic fluorination: concept, mechanism and applications in positron emission tomography.Sex steroid hormones and brain function: PET imaging as a tool for research.Carbon-11 radiolabelling of organosulfur compounds: (11) C synthesis of the progesterone receptor agonist tanaproget.Synthesis and preliminary evaluation of a 18 F-labeled ethisterone derivative [18 F]EAEF for progesterone receptor targeting.Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.
P2860

Development of [F-18]fluorine-substituted Tanaproget as a progesterone receptor imaging agent for positron emission tomography.

Item
http://www.wikidata.org/entity/Q34117145
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of [F-18]fluorine- ...... positron emission tomography.
@ast
Development of [F-18]fluorine- ...... positron emission tomography.
@en
Development of [F-18]fluorine- ...... positron emission tomography.
@nl
type
label
Development of [F-18]fluorine- ...... positron emission tomography.
@ast
Development of [F-18]fluorine- ...... positron emission tomography.
@en
Development of [F-18]fluorine- ...... positron emission tomography.
@nl
prefLabel
Development of [F-18]fluorine- ...... positron emission tomography.
@ast
Development of [F-18]fluorine- ...... positron emission tomography.
@en
Development of [F-18]fluorine- ...... positron emission tomography.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Development of [F-18]fluorine- ...... r positron emission tomography
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698